Literature DB >> 20411409

Phospholipids and lipid-based formulations in oral drug delivery.

Gert Fricker1, Torsten Kromp, Armin Wendel, Alfred Blume, Jürgen Zirkel, Herbert Rebmann, Constanze Setzer, Ralf-Olaf Quinkert, Frank Martin, Christel Müller-Goymann.   

Abstract

Phospholipids become increasingly important as formulation excipients and as active ingredients per se. The present article summarizes particular features of commonly used phospholipids and their application spectrum within oral drug formulation and elucidates current strategies to improve bioavailability and disposition of orally administered drugs. Advantages of phospholipids formulations not only comprise enhanced bioavailability of drugs with low aqueous solubility or low membrane penetration potential, but also improvement or alteration of uptake and release of drugs, protection of sensitive active agents from degradation in the gastrointestinal tract, reduction of gastrointestinal side effects of non-steroidal anti-inflammatory drugs and even masking of bitter taste of orally applied drugs. Technological strategies to achieve these effects are highly diverse and offer various possibilities of liquid, semi-liquid and solid lipid-based formulations for drug delivery optimization.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20411409     DOI: 10.1007/s11095-010-0130-x

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  96 in total

1.  Improved intestinal absorption of calcitonin by mucoadhesive delivery of novel pectin-liposome nanocomplexes.

Authors:  Nartaya Thirawong; Jringjai Thongborisute; Hirofumi Takeuchi; Pornsak Sriamornsak
Journal:  J Control Release       Date:  2007-11-04       Impact factor: 9.776

2.  Mixed-micellar proliposomal systems for enhanced oral delivery of progesterone.

Authors:  Praveen Potluri; Guru V Betageri
Journal:  Drug Deliv       Date:  2006 May-Jun       Impact factor: 6.419

3.  Phosphatidylcholine inhibits and lysophosphatidylcholine enhances the lymphatic absorption of alpha-tocopherol in adult rats.

Authors:  S I Koo; S K Noh
Journal:  J Nutr       Date:  2001-03       Impact factor: 4.798

4.  Oral delivery of antigens in liposomes with some lipid compositions modulates oral tolerance to the antigens.

Authors:  Kazuyoshi Masuda; Kazutoshi Horie; Ryuji Suzuki; Takayoshi Yoshikawa; Koichiro Hirano
Journal:  Microbiol Immunol       Date:  2002       Impact factor: 1.955

5.  Comparison of the lymphatic transport of halofantrine administered in disperse systems containing three different unsaturated fatty acids.

Authors:  R Holm; A Müllertz; G P Pedersen; H G Kristensen
Journal:  Pharm Res       Date:  2001-09       Impact factor: 4.200

6.  New surface-modified lipid nanoparticles as delivery vehicles for salmon calcitonin.

Authors:  Marcos Garcia-Fuentes; Dolores Torres; Maria José Alonso
Journal:  Int J Pharm       Date:  2005-04-07       Impact factor: 5.875

7.  Gastroprotective capability of exogenous phosphatidylcholine in experimentally induced chronic gastric ulcers in rats.

Authors:  B S Dunjic; J Axelson; A Ar'Rajab; K Larsson; S Bengmark
Journal:  Scand J Gastroenterol       Date:  1993-01       Impact factor: 2.423

8.  Clinical trial: comparison of ibuprofen-phosphatidylcholine and ibuprofen on the gastrointestinal safety and analgesic efficacy in osteoarthritic patients.

Authors:  F L Lanza; U K Marathi; B S Anand; L M Lichtenberger
Journal:  Aliment Pharmacol Ther       Date:  2008-06-11       Impact factor: 8.171

9.  Development and physicochemical evaluation of pharmacosomes of diclofenac.

Authors:  Ajay Semalty; Mona Semalty; Devendra Singh; M S M Rawat
Journal:  Acta Pharm       Date:  2009-09       Impact factor: 2.230

10.  Cyclosporin nanoparticulate lipospheres for oral administration.

Authors:  Tania Bekerman; Jacob Golenser; Abraham Domb
Journal:  J Pharm Sci       Date:  2004-05       Impact factor: 3.534

View more
  47 in total

1.  Development of lipid-based nanoparticles for enhancing the oral bioavailability of paclitaxel.

Authors:  Deepti Pandita; Alka Ahuja; Viney Lather; Biju Benjamin; Tathagata Dutta; Thirumurthy Velpandian; Roop Krishen Khar
Journal:  AAPS PharmSciTech       Date:  2011-06-03       Impact factor: 3.246

Review 2.  Oral bioavailability: issues and solutions via nanoformulations.

Authors:  Kamla Pathak; Smita Raghuvanshi
Journal:  Clin Pharmacokinet       Date:  2015-04       Impact factor: 6.447

Review 3.  Transforming lipid-based oral drug delivery systems into solid dosage forms: an overview of solid carriers, physicochemical properties, and biopharmaceutical performance.

Authors:  Angel Tan; Shasha Rao; Clive A Prestidge
Journal:  Pharm Res       Date:  2013-06-18       Impact factor: 4.200

4.  Phospholipid-Coated Hydrophobic Mesoporous Silica Nanoparticles Enhance Thrombectomy by High-Intensity Focused Ultrasound with Low Production of Embolism-Inducing Clot Debris.

Authors:  Nicholas T Blum; Ciara M Gyorkos; Spencer J Narowetz; Evan N Mueller; Andrew P Goodwin
Journal:  ACS Appl Mater Interfaces       Date:  2019-09-26       Impact factor: 9.229

5.  A gastrointestinal transit study on amphotericin B-loaded solid lipid nanoparticles in rats.

Authors:  Hilda Amekyeh; Nashiru Billa; Kah-Hay Yuen; Sherlyn Lim Sheau Chin
Journal:  AAPS PharmSciTech       Date:  2015-01-15       Impact factor: 3.246

Review 6.  Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers.

Authors:  Laura M Ensign; Richard Cone; Justin Hanes
Journal:  Adv Drug Deliv Rev       Date:  2011-12-24       Impact factor: 15.470

7.  Physicochemical Properties of Solid Phospholipid Particles as a Drug Delivery Platform for Improving Oral Absorption of Poorly Soluble Drugs.

Authors:  Kohsaku Kawakami; Aoi Miyazaki; Mayuko Fukushima; Keiko Sato; Yuko Yamamura; Kohta Mohri; Shinji Sakuma
Journal:  Pharm Res       Date:  2016-11-07       Impact factor: 4.200

Review 8.  Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems.

Authors:  John C Kraft; Jennifer P Freeling; Ziyao Wang; Rodney J Y Ho
Journal:  J Pharm Sci       Date:  2013-11-25       Impact factor: 3.534

9.  Caco-2 cell transport of purple sweet potato anthocyanins-phospholipids complex.

Authors:  Mei Cheng; Xin Zhang; Jinxuan Cao; Xiaojie Zheng; Zhicheng Zhang
Journal:  J Food Sci Technol       Date:  2017-10-28       Impact factor: 2.701

10.  Combination of Phospholipid Complex and Matrix Dispersion.

Authors:  Ravi Kumar Chakravarti; Shamandeep Kaur; Sanjaya K Samal; Mahesh C Kashyap; Abhay T Sangamwar
Journal:  AAPS PharmSciTech       Date:  2021-06-22       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.